This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Burstein SA (2000) Thrombocytopenia due to decreased platelet production. In: Hoffman, R, Benz EJ, Shattil SJ et al. (Hrsg) Hematology. Basic Principles and Practice, 3rd edn. Churchill Livingstone, New York, pp 2115–2125
Chemnitz J, Draube A, Scheid C, Staib P, Schulz A, Diehl V, Söhngen D (2002) Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab. Am J Hematol 71: 105–108
Cines DB, Blanchette VS (2002) Medical progress. Immune thrombocyto-penic purpura. N Engl J Med 346: 995–1008
Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) Hämolytisch-urämisches Syndrome: Bilaterale Nierenrindennekrosen bei akuten erworbenen hämolytischen Anämien. Schweiz Med Wochenschr 85: 905–909
George JN (2001) Platelet kinetics and pathophysiology of thrombocytopenia. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (Hrsg) Hemostasis and thrombosis. Basic principles & clinical practice, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 447–459
George JN (2002) Platelets. Lancet 355: 1531–1539
George JN, Shattil SJ (2000) Acquired disorders of platelet function. In: Hoffman R, Benz EJ, Shattil SJ et al. (Hrsg) Hematology. Basic principles and practice, 3rd edn. Churchill Livingstone, New York, pp 2172–2186
Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M (1999) Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 82:1386–1389
Giagounidis AAN, Anhuf J, Schneider P, Germing U, Söhngen D, Quabeck K, Aul C (2002) Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD 20 monoclonal antibody rituximab: a pilot study. Eur J Haematol 69: 95–100
Harrington WJ, Minnich V, Hollingsworth JW, Moore CV (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38: 1–10
Kiefel V, Santoso S (1999) Idiopathische thrombozytopenische Purpura und weitere immunologisch bedingte Thrombozytopenien. In: Müller-Berghaus G, Pötzsch B (Hrsg) Hämostaseologie. Molekulare und zelluläre Mechanismen, Pathophysiologie und Klinik. Springer, Berlin Heidelberg New York Tokyo, S 95–106
Moake JL (2002) Mechanisms of disease. Thrombotic microangiopathies. N Engl J Med 347: 589–600
Moschcowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 24:21–24
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Heidelberg
About this chapter
Cite this chapter
Söhngen, D. (2005). Störungen des thrombozytären Systems und der Gefäßwand. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_31
Download citation
DOI: https://doi.org/10.1007/3-540-27385-9_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21226-3
Online ISBN: 978-3-540-27385-1
eBook Packages: Medicine (German Language)